Bioquell Share Discussion Threads

[mutley28] 29/4/2009 12:48

Bought a few earlier, very little stock on offer at the time. Have punted these many times in the past. These got quite lively around the time of bird flu so may motor on up from here??? DYOR

[scotswhaehae] 29/4/2009 11:58

Getting underway as expected

Hospital bio-decontamination in the USA likely to step up with swine flu pandemic?

Standby for lift off...dyor

[scotswhaehae] 20/4/2009 14:16

A few buyers appearing...looks heavily undervalued to me

Very little net buying and we are 150p plus in my view...dyor of course

[money multipier] 24/3/2009 23:34

A solid set of results and a nice cash position. Still waiting for the decision from the PASA tender but if that comes good this has to be a very attractive share.

[money multipier] 12/3/2009 23:49

It's not awards I want to see but contracts. Still no follow up yet from the showcase hospitals but I understand there will be an update on the situation with the finals planned for later this month. Having said that I guess the award shows the process was very effective.

[pawdaw] 12/3/2009 22:35

You'd think they could blow their own trumpet a bit more.

[the_doctor] 09/2/2009 21:49

How much of BQE's profit is recurring?
Is it now used in a number of hospitals, or are they vying for a big conract?

[money multipier] 31/1/2009 13:03

Anybody know how things are going at BQE? Since director buys at 175/180p we've had trading update refering to commercial discussions with 7 hospitals about continuing the bioquell proactive service. As far as I can make out the DoH funding finished in 2008 and nothing announced since. Has this showcase stuff come to nothing? Is that why share price now just above £1?

They should have good things to say about 2008 but what's their latest view likely to be for 2009?

[pinkie] 12/1/2009 16:15

Looks like 160ish before the news breaks with further good news from the states

[fathert] 27/8/2008 08:13

SCOTSWHAEHEA -- likely to fall back a bit?

oh dear will that cause some pain never mind -- i hear BQE are in for a rough time in the next month -- look to a 30% loss i think the time to sell is now scots and buy back in latter -- good luck

sub 150p by oct

[scotswhaehae] 27/8/2008 08:05

hmmm...a bit dull RNS...likely to fall back a bit?

[scotswhaehae] 13/8/2008 10:37

Decent buyer about...

[wes1] 10/7/2008 08:59

Rumour of the day

Bioquell, the provider of hydrogen vapour kit to hospitals designed to kill MRSA and other infections, surged 25½p to 170p as 6 per cent of the company changed hands. An institution is thought to be snapping up stakes held by two forced sellers. Department of Health trials at seven hospitals of Bioquell's RoboCleaner are said to be going well.

[scotswhaehae] 09/7/2008 13:19

For once I might be right!

[scotswhaehae] 09/7/2008 10:17

Decent volume...hopefully a seller cleared!

[wes1] 26/6/2008 05:49

Robot blasts bleach vapour into hospital rooms in battle against superbugs

By Daily Mail Reporter
Last updated at 3:48 PM on 25th June 2008

Health chiefs are trialling a hi-tech machine to blast bleach vapour into treatment rooms to battle deadly infections including MRSA and C-difficile.

The computer-operated machine, which bears a passing resemblance to StarWars Robot R2-D2, pumps hydrogen peroxide vapour into a room.

It remains inside the sealed room for 90 minutes. Then vapour is then pumped out without leaving residue and the room is ready for the next patient.

The machine was created by Hampshire-based Bioquell, whose research and development director David Watling designed the Star Wars robot character R2-D2.

It has started four-month trials at seven hospitals across the country, including the Manchester Royal Infirmary.

Chief nurse Gill Heaton, who is in charge of infection control at the hospital, said: 'This is a landmark project, and we are very pleased to have been chosen as one of the seven pioneering sites.

'Developing an infection in hospital is a worry for many patients and infection control is a top priority for the six hospitals in our trust. We've worked very hard over the past year to significantly reduce infections.

'As a result, we are one of the best performing trusts in the north west, and this expertise in infection control has been reinforced by our selection.'

The trust is also testing a skin disinfectant to use before attaching drips to patients.

Paul Cryer, project manager for the trials, said: 'We chose Manchester because of their very clear determination to significantly reduce infection in their hospitals, and also their enthusiasm for sharing what they have learnt with other NHS hospitals and staff.'

The hospitals will collect evidence of how effective the products they test are and share the information successful products with other hospitals.

The other six Showcase Hospitals are in Wolverhampton, Calderdale and Huddersfield,Southampton, County Durham and Darlington and Lewisham.

The Department of Health says tackling healthcare infections is one of its top priorities.

Hospitals have been given targets to cut MRSA infections by half and C-difficile infections by 30 per cent by 2011.

[wes1] 26/6/2008 05:46

Manchester Evening News

The superbug buster...
Amanda Crook
25/ 6/2008

A SUPERBUG-beating robot is being tested in Manchester hospitals.

The machine sprays powerful bleach into isolation wards to kill deadly infections including MRSA and C-difficile.

Central Manchester hospitals trust has begun a four-month trial of the 'bioquell' robot, which deep-cleans rooms with hydrogen peroxide vapour in between patients.

The treatment room is sealed with the robot inside and then left for 90 minutes. The vapour is then pumped out and the room is ready for the next patient.

Central Manchester is one of seven trusts across the country to be picked for the trials.

Chief nurse Gill Heaton who is in charge of infection control at Manchester Royal Infirmary, said: "This is a landmark project, and we are very pleased to have been chosen as one of the seven pioneering sites.

"Developing an infection in hospital is a worry for many patients, and infection control is a top priority for the six hospitals in our Trust. We've worked very hard over the past year to significantly reduce infections.

Trusts

"As a result, we are one of the best performing trusts in the north west, and this expertise in infection control has been reinforced by our selection ."

The trust is also testing a skin disinfectant to use before attaching drips to patients.

Paul Cryer, project manager for the trials, said: "We chose Manchester because of their very clear determination to significantly reduce infection in their hospitals, and also their enthusiasm for sharing what they have learnt with other NHS hospitals and staff."

The hospitals will collect evidence of how effective each product is and share the information.

The Department of Health says tackling healthcare infections is one of its top priorities.

Hospitals have been given targets to cut MRSA infections by half and C-difficile infections by 30pc by 2011.

[wes1] 17/6/2008 06:30

A CLEANING machine made by Andover's Bioquell has been credited with eradicating MRSA at Winchester hospital - and now a consultant plans to climb a mountain to buy one.

Dr Matthew Dryden is setting off this week to climb Mt Kinabalu in Borneo and in the process hopes to raise money to pay for a Bioquell machine to help eradicate all superbugs from hospital wards.

He said: "I am hoping to get to the top of Mt Kinabalu in Borneo this week - actually it is more of a walk than a climb and lots of people have done it.

"In the process I hope to raise money for Winchester and Andover hospitals to purchase a Bioquell machine to help in the fight against superbugs including MRSA, C Diff and norovirus. "Research carried out last year showed that by using the Bioquell device we were able to completely eradicate MRSA from the clinical environment. This year we have had no serious blood stream MRSA infections."

Bioquell will match any donations towards the purchase of their technology. Anyone who would like to support the Trust to beat superbugs may sponsor Dr Dryden through the Winchester and Eastleigh Charitable Trust Fund at the hospital or on line via The Bioquell is state-of-the-art hydrogen peroxide vapour (HPV) equipment that is suitable for use in the hospital environment.

[thelionsshare] 02/6/2008 18:50

Well Scots The options seem pretty good deal to me as they 'will vest upon the achievement of performance criteria, namely the growth of pre-tax earnings per share by RPI + 7.5%' .The exercise price of 174.5p is hardly a giveaway particularly if the market tanks. I got no quibbles with it as a PI myself. I think BIOQUELL has missed a trick in the NHS with mrsa perhaps more due to the shortsightedness of nhs trusts than anything else but I love the diverse products and potential of this company. I wonder how the wound healing side is going and would love to see it spun off if it is a commercial success.

[scotswhaehae] 29/5/2008 14:07

...directors now have their options priced (low...it was ever thus!) so we should now steam ahead!

[finsburycircus] 28/5/2008 13:09

xd 2p today...so up a nice few percent

situation building very well...lots more to go for of course...dyor

[fatfin] 27/5/2008 17:56

Another mention in Moneyweek last Friday

Fatfin

[finsburycircus] 27/5/2008 10:28

There does seem to be a buyer scooping up stock as it appears...
From a chart viewpoint it may be that a spike to 250p or so is quite possible.
Interesting situation on fundamentals too with health, defence and laboratory aspects.

[scotswhaehae] 13/5/2008 10:49

looks like buyers are appearing...

won't take much to put us 200p plus again imo...